Previous studies have demonstrated that suppressing MRPL13 expression leads to mitochondrial ribosome defects, weakening OXPHOS activity and affecting the invasiveness of hepatocellular carcinoma cells [39]. Here, MRPL13 is linked to hepatocellular carcinoma.